Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002695 · ClinicalTrials.gov registry record
Analysis of Tumor Tissue and Lymph Nodes Surgically Removed From Patients With Cancers of the Head and Neck
A clinical trial, sponsored by ECOG-ACRIN Cancer Research Group.
- Completed
- Registry status
- 530
- Enrollment target
NCT00002695: Completed study, sponsored by ECOG-ACRIN Cancer Research Group.
NCT00002695 is a clinical trial that has completed, run by ECOG-ACRIN Cancer Research Group. The registered enrollment target is 530 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002695 has completed, sponsored by ECOG-ACRIN Cancer Research Group.
- COMPLETED
- Registry status
- 530 participants
- Enrollment target
Study Summary
RATIONALE: Diagnostic procedures, such as analysis of tumor tissue and lymph nodes that have been surgically removed, may improve the treatment of patients with cancers of the head and neck. PURPOSE: Diagnostic trial to determine if analyzing tumor tissue and lymph nodes surgically removed from patients with cancers of the head and neck can predict recurrence of the cancer.
Interventions
- OTHER laboratory biomarker analysis
- GENETIC mutation analysis
- GENETIC DNA stability analysis
- GENETIC microsatellite instability analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 530 participants |
| Start Date | 1996-04-30 |
| Est. Completion | 2011-05-27 |
What the finished NCT00002695 record still lists
NCT00002695 is an observational study that tracks outcomes without assigning an intervention. The registered 530 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 4 interventions - of which laboratory biomarker analysis is the first listed.
NCT00002695 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002695 about?
NCT00002695 is a clinical study titled "Analysis of Tumor Tissue and Lymph Nodes Surgically Removed From Patients With Cancers of the Head and Neck". RATIONALE: Diagnostic procedures, such as analysis of tumor tissue and lymph nodes that have been surgically removed, may improve the treatment of patients with cancers of the head and neck. PURPOSE: Diagnostic trial to determine if analyzing tumor tissue and lymph nodes surgically removed from pat...
What is the current status of trial NCT00002695?
This trial is currently completed. The enrollment target is 530 participants. The study started on 1996-04-30. Estimated completion is 2011-05-27.
What interventions are being tested in trial NCT00002695?
The interventions under investigation include: laboratory biomarker analysis (OTHER), mutation analysis (GENETIC), DNA stability analysis (GENETIC), microsatellite instability analysis (GENETIC).
Who is sponsoring clinical trial NCT00002695?
This trial is sponsored by ECOG-ACRIN Cancer Research Group, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06646276 · 530 participants · Phase 3
A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
- NCT06703476 · 530 participants · Phase 3
A Study of Surgical Techniques During Cystectomy
- NCT06880744 · 530 participants · Phase 3
A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab
- NCT07138040 · 530 participants · NA
Re-Engaging AYA Survivors in Cancer-Related Healthcare
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI